CashuAlterity Therapeutics: Key Developments and Future Prospects in Neurodegenerative Disease Research3 days ago
CashuAlterity Therapeutics Advances PBT434 for Neurodegenerative Diseases: Promising Phase 2 Results5 days ago
CashuAlterity Therapeutics Advances PBT2 for Neurodegenerative Diseases, Enhancing Cognitive Function7 days ago